Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Suspends Two Leukemia Drugs (China)

This article was originally published in PharmAsia News

Executive Summary

China's State Food and Drug Administration has announced it is suspending the sale of two drugs used to treat leukemia and rheumatoid arthritis. The drugs, methotrexate and cytarabin hydrochloride, became the subject of scrutiny after the release of information by the National Center for ADR Monitoring. Patients taking the two drugs experienced adverse side effects including impaired leg movement and urine retention. The Chinese results are only the latest of 12,500 accounts of undesirable reactions to methotrexate. (Click here for more - May Require Free Registration



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts